Article
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine.
The Journal of infectious diseases - 1 Jan 2004
Ferrantelli Flavia, Kitabwalla Moiz, Rasmussen Robert A, Cao Chuanhai, Chou Ting-Chao, Katinger Hermann, Stiegler Gabriela, Cavacini Lisa A, Bai Yun, Cotropia Joseph, Ugen Kenneth E, Ruprecht Ruth M
Abstract excerpt
Human immunodeficiency virus type 1 (HIV-1) is phylogenetically classified into groups and clades (or subtypes). Human neutralizing monoclonal antibodies (nMAbs), originally isolated from individuals infected with HIV-1 group M-clade B, neutralized not only primary HIV-1 clade B isolates in vitro...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.